SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition.
Lara PN Jr, Quinn DI, Margolin K, Meyers FJ, Longmate J, Frankel P, Mack PC, Turrell C, Valk P, Rao J, Buckley P, Wun T, Gosselin R, Galvin I, Gumerlock PH, Lenz HJ, Doroshow JH, Gandara DR; California Cancer Consortium.
Lara PN Jr, et al. Among authors: gumerlock ph.
Clin Cancer Res. 2003 Oct 15;9(13):4772-81.
Clin Cancer Res. 2003.
PMID: 14581348
Clinical Trial.